IOBT: Io Biotech Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Io Biotech Inc (IOBT).
$60.61M Market Cap.
IOBT Market Cap. (MRY)
IOBT Shares Outstanding (MRY)
IOBT Assets (MRY)
Total Assets
$67.70M
Total Liabilities
$20.68M
Total Investments
$268.00K
IOBT Income (MRY)
Revenue
$0
Net Income
-$95.49M
Operating Expense
$95.18M
IOBT Cash Flow (MRY)
CF Operations
-$82.35M
CF Investing
-$44.00K
CF Financing
$0
IOBT Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $67,699,000 (-55.08%) | $150,718,000 (-0.72%) | $151,805,000 (-31.71%) | $222,288,000 (3832.21%) |
Assets Current | $64,951,000 (-55.89%) | $147,255,000 (-0.65%) | $148,219,000 (-33.16%) | $221,738,000 (3835.01%) |
Assets Non-Current | $2,748,000 (-20.65%) | $3,463,000 (-3.43%) | $3,586,000 (552.00%) | $550,000 (2955.56%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $47,015,000 (-64.69%) | $133,162,000 (-4.10%) | $138,854,000 (-34.48%) | $211,924,000 (700.30%) |
Property Plant & Equipment Net | $2,363,000 (-23.92%) | $3,106,000 (-3.96%) | $3,234,000 (1986.45%) | $155,000 (0%) |
Cash & Equivalents | $60,031,000 (-58.08%) | $143,193,000 (0.42%) | $142,590,000 (-32.59%) | $211,531,000 (6112.36%) |
Accumulated Other Comprehensive Income | -$6,851,000 (29.14%) | -$9,669,000 (4.65%) | -$10,141,000 (-581.06%) | -$1,489,000 (-175.93%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $268,000 (0.00%) | $268,000 (0.00%) | $268,000 (0.00%) | $268,000 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $268,000 (0.00%) | $268,000 (0.00%) | $268,000 (0.00%) | $268,000 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $4,661,000 (20.19%) | $3,878,000 (-3.15%) | $4,004,000 (1.93%) | $3,928,000 (652.49%) |
Accumulated Retained Earnings (Deficit) | -$359,313,000 (-36.20%) | -$263,822,000 (-48.43%) | -$177,739,000 (-67.23%) | -$106,281,000 (-176.76%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $1,915,000 (-23.22%) | $2,494,000 (-10.61%) | $2,790,000 (0%) | $0 (0%) |
Debt Current | $717,000 (9.47%) | $655,000 (27.18%) | $515,000 (0%) | $0 (0%) |
Debt Non-Current | $1,198,000 (-34.86%) | $1,839,000 (-19.16%) | $2,275,000 (0%) | $0 (0%) |
Total Liabilities | $20,684,000 (17.82%) | $17,556,000 (35.56%) | $12,951,000 (24.96%) | $10,364,000 (239.80%) |
Liabilities Current | $19,486,000 (23.98%) | $15,717,000 (47.22%) | $10,676,000 (3.60%) | $10,305,000 (237.87%) |
Liabilities Non-Current | $1,198,000 (-34.86%) | $1,839,000 (-19.16%) | $2,275,000 (3755.93%) | $59,000 (0%) |
IOBT Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $23,693,000 (0.33%) | $23,614,000 (-3.37%) | $24,438,000 (120.52%) | $11,082,000 (559.25%) |
Research & Development Expense | $71,484,000 (5.39%) | $67,829,000 (44.36%) | $46,986,000 (55.83%) | $30,152,000 (256.24%) |
Operating Expenses | $95,177,000 (4.08%) | $91,443,000 (28.03%) | $71,424,000 (73.22%) | $41,234,000 (306.45%) |
Interest Expense | $0 (0%) | $0 (0%) | $302,000 (-16.34%) | $361,000 (1288.46%) |
Income Tax Expense | $1,443,000 (69.37%) | $852,000 (-33.07%) | $1,273,000 (1772.06%) | $68,000 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$95,491,000 (-10.93%) | -$86,083,000 (-20.47%) | -$71,458,000 (-5.27%) | -$67,879,000 (-463.69%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$95,491,000 (-10.93%) | -$86,083,000 (-20.47%) | -$71,458,000 (-5.27%) | -$67,879,000 (-463.69%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $7,108,000 (178.53%) |
Net Income Common Stock | -$95,491,000 (-10.93%) | -$86,083,000 (-20.47%) | -$71,458,000 (4.71%) | -$74,987,000 (-413.82%) |
Weighted Average Shares | $65,880,914 (51.31%) | $43,539,976 (51.10%) | $28,815,267 (564.62%) | $4,335,629 (2346.74%) |
Weighted Average Shares Diluted | $65,880,914 (51.31%) | $43,539,976 (51.10%) | $28,815,267 (564.62%) | $4,335,629 (2346.74%) |
Earning Before Interest & Taxes (EBIT) | -$94,048,000 (-10.34%) | -$85,231,000 (-21.96%) | -$69,883,000 (-3.61%) | -$67,450,000 (-461.33%) |
Gross Profit | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Income | -$95,177,000 (-4.08%) | -$91,443,000 (-28.03%) | -$71,424,000 (-73.22%) | -$41,234,000 (-306.45%) |
IOBT Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$44,000 (86.38%) | -$323,000 (53.19%) | -$690,000 (-350.98%) | -$153,000 (0%) |
Net Cash Flow from Financing | $0 (0%) | $71,860,000 (0%) | $0 (0%) | $252,951,000 (4857.88%) |
Net Cash Flow from Operations | -$82,347,000 (-14.79%) | -$71,737,000 (-20.10%) | -$59,729,000 (-46.95%) | -$40,646,000 (-308.26%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$82,391,000 (-41095.50%) | -$200,000 (99.67%) | -$60,419,000 (-128.48%) | $212,152,000 (4470.66%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | -$44,000 (86.38%) | -$323,000 (53.19%) | -$690,000 (-350.98%) | -$153,000 (0%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $0 (0%) | $71,860,000 (0%) | $0 (0%) | $103,350,000 (0%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | -$771,000 (-196.01%) | $803,000 (109.42%) | -$8,522,000 (-126.77%) | -$3,758,000 (-1009.93%) |
Share Based Compensation | $6,526,000 (-19.02%) | $8,059,000 (14.47%) | $7,040,000 (293.08%) | $1,791,000 (2698.44%) |
Depreciation Amortization & Accretion | $849,000 (12.30%) | $756,000 (40.00%) | $540,000 (26900.00%) | $2,000 (0%) |
IOBT Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | - | - | - | - |
Profit Margin | - | - | - | - |
EBITDA Margin | - | - | - | - |
Return on Average Equity (ROAE) | -115.30% (-73.91%) | -66.30% (-52.76%) | -43.40% (48.88%) | -84.90% (-271.17%) |
Return on Average Assets (ROAA) | -96.10% (-61.24%) | -59.60% (-45.72%) | -40.90% (37.84%) | -65.80% (66.01%) |
Return on Sales (ROS) | - | - | - | - |
Return on Invested Capital (ROIC) | 2769.80% (-27.85%) | 3838.80% (437.54%) | -1137.30% (-102.95%) | 38542.90% (2151.73%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% |
Price to Earnings Ratio (P/E) | -0.63 (33.19%) | -0.95 (-2.37%) | -0.93 (-150.54%) | -0.37 |
Price to Sales Ratio (P/S) | - | - | - | - |
Price to Book Ratio (P/B) | 1.29 (38.60%) | 0.93 (94.97%) | 0.48 (-45.17%) | 0.87 |
Debt to Equity Ratio (D/E) | 0.44 (233.33%) | 0.13 (41.94%) | 0.09 (89.80%) | 0.05 (156.98%) |
Earnings Per Share (EPS) | -1.45 (26.77%) | -1.98 (20.16%) | -2.48 (85.66%) | -17.3 (78.99%) |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -1.25 (24.41%) | -1.66 (21.08%) | -2.1 (77.72%) | -9.41 (83.25%) |
Book Value Per Share (BVPS) | 0.71 (-76.65%) | 3.06 (-36.54%) | 4.82 (-90.14%) | 48.88 (124.53%) |
Tangible Assets Book Value Per Share (TABVPS) | 1.03 (-70.31%) | 3.46 (-34.28%) | 5.27 (-89.72%) | 51.27 (60.71%) |
Enterprise Value Over EBIT (EV/EBIT) | 0 (0%) | 0 (0%) | 1 (150.00%) | -2 |
Enterprise Value Over EBITDA (EV/EBITDA) | 0.19 (-59.31%) | 0.46 (-61.08%) | 1.19 (157.62%) | -2.06 |
Asset Turnover | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Current Ratio | 3.33 (-64.43%) | 9.37 (-32.51%) | 13.88 (-35.48%) | 21.52 (1064.39%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$82,391,000 (-14.34%) | -$72,060,000 (-19.27%) | -$60,419,000 (-48.09%) | -$40,799,000 (-309.79%) |
Enterprise Value (EV) | -$17,555,559 (55.03%) | -$39,041,882 (52.57%) | -$82,321,886 (-159.25%) | $138,940,709 |
Earnings Before Tax (EBT) | -$94,048,000 (-10.34%) | -$85,231,000 (-21.44%) | -$70,185,000 (-3.50%) | -$67,811,000 (-463.12%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$93,199,000 (-10.33%) | -$84,475,000 (-21.82%) | -$69,343,000 (-2.81%) | -$67,448,000 (-461.32%) |
Invested Capital | -$9,903,000 (-73.80%) | -$5,698,000 (-528.74%) | $1,329,000 (194.03%) | $452,000 (156.36%) |
Working Capital | $45,465,000 (-65.44%) | $131,538,000 (-4.37%) | $137,543,000 (-34.95%) | $211,433,000 (8079.23%) |
Tangible Asset Value | $67,699,000 (-55.08%) | $150,718,000 (-0.72%) | $151,805,000 (-31.71%) | $222,288,000 (3832.21%) |
Market Capitalization | $60,610,441 (-51.06%) | $123,856,118 (86.88%) | $66,275,114 (-64.06%) | $184,417,709 |
Average Equity | $82,829,500 (-36.22%) | $129,872,250 (-21.08%) | $164,553,250 (86.33%) | $88,310,500 (400.20%) |
Average Assets | $99,317,500 (-31.23%) | $144,417,500 (-17.33%) | $174,694,500 (53.28%) | $113,970,500 (1411.95%) |
Invested Capital Average | -$3,395,500 (-52.93%) | -$2,220,250 (-136.13%) | $6,144,500 (3611.14%) | -$175,000 (75.07%) |
Shares | 65,880,914 (0.00%) | 65,880,914 (128.63%) | 28,815,267 (0.00%) | 28,815,267 (12.00%) |
